Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the β-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Interleukin-2 Receptor alpha Subunit
  • Lymphoma
  • Radioimmunotherapy
  • Yttrium Radioisotopes

abstract

  • Our findings suggested that (90)Y-7G7/B6 is a potentially useful radioimmunotherapeutic agent for the treatment of patients with CD25-expressing lymphomas.

publication date

  • June 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2925030

Digital Object Identifier (DOI)

  • 10.1089/cbr.2008.0577

PubMed ID

  • 19538052

Additional Document Info

start page

  • 303

end page

  • 9

volume

  • 24

number

  • 3